Yoichiro Hirakawa

7.5k total citations
116 papers, 4.1k citations indexed

About

Yoichiro Hirakawa is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Epidemiology. According to data from OpenAlex, Yoichiro Hirakawa has authored 116 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Cardiology and Cardiovascular Medicine, 27 papers in Endocrinology, Diabetes and Metabolism and 25 papers in Epidemiology. Recurrent topics in Yoichiro Hirakawa's work include Blood Pressure and Hypertension Studies (17 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (13 papers) and Nutritional Studies and Diet (12 papers). Yoichiro Hirakawa is often cited by papers focused on Blood Pressure and Hypertension Studies (17 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (13 papers) and Nutritional Studies and Diet (12 papers). Yoichiro Hirakawa collaborates with scholars based in Japan, Australia and United States. Yoichiro Hirakawa's co-authors include Toshiharu Ninomiya, Takanari Kitazono, Jun Hata, Yutaka Kiyohara, Daigo Yoshida, Naoko Mukai, Tomoyuki Ohara, Yasufumi Doi, Udai Nakamura and Mark Woodward and has published in prestigious journals such as Circulation, PLoS ONE and American Journal of Clinical Nutrition.

In The Last Decade

Yoichiro Hirakawa

115 papers receiving 4.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yoichiro Hirakawa Japan	35	989	945	822	642	582	116	4.1k
Di Zhao United States	39	872 0.9×	1.5k 1.6×	634 0.8×	843 1.3×	490 0.8×	197	5.3k
Shao‐Yuan Chuang Taiwan	37	735 0.7×	2.0k 2.1×	763 0.9×	614 1.0×	764 1.3×	157	4.8k
Hironori Imano Japan	34	662 0.7×	1.5k 1.5×	808 1.0×	732 1.1×	530 0.9×	179	4.1k
James G. Terry United States	36	780 0.8×	1.4k 1.5×	789 1.0×	691 1.1×	603 1.0×	127	4.0k
Masahiko Kiyama Japan	33	816 0.8×	1.3k 1.4×	603 0.7×	749 1.2×	566 1.0×	160	3.6k
Daiva Rastenytė Lithuania	28	793 0.8×	1.4k 1.5×	515 0.6×	1.1k 1.7×	385 0.7×	117	4.6k
Sarah R. Preis United States	35	753 0.8×	1.4k 1.5×	1.1k 1.3×	879 1.4×	401 0.7×	80	4.8k
Yumihiro Tanizaki Japan	37	888 0.9×	1.1k 1.2×	745 0.9×	1.1k 1.7×	1.0k 1.7×	58	4.4k
B. Gwen Windham United States	39	543 0.5×	1.4k 1.4×	1.4k 1.7×	661 1.0×	362 0.6×	151	5.1k
Rachel H. Mackey United States	37	1.3k 1.3×	1.9k 2.0×	720 0.9×	665 1.0×	987 1.7×	109	4.8k

Countries citing papers authored by Yoichiro Hirakawa

Since Specialization

Citations

This map shows the geographic impact of Yoichiro Hirakawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoichiro Hirakawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoichiro Hirakawa more than expected).

Fields of papers citing papers by Yoichiro Hirakawa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoichiro Hirakawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoichiro Hirakawa. The network helps show where Yoichiro Hirakawa may publish in the future.

Co-authorship network of co-authors of Yoichiro Hirakawa

This figure shows the co-authorship network connecting the top 25 collaborators of Yoichiro Hirakawa. A scholar is included among the top collaborators of Yoichiro Hirakawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoichiro Hirakawa. Yoichiro Hirakawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hirakawa, Yoichiro, Jun Hata, Takanori Honda, et al.. (2023). Serum Mac-2 Binding Protein Glycosylation Isomer Concentrations Are Associated With Incidence of Type 2 Diabetes. The Journal of Clinical Endocrinology & Metabolism. 108(7). e425–e433. 5 indexed citations

Hirabayashi, Naoki, Jun Hata, Yoshihiko Furuta, et al.. (2022). Association Between Diabetes and Gray Matter Atrophy Patterns in a General Older Japanese Population: The Hisayama Study. Diabetes Care. 45(6). 1364–1371. 14 indexed citations

Honda, Takanori, Yoichiro Hirakawa, Jun Hata, et al.. (2022). Active commuting, commuting modes and the risk of diabetes: 14‐year follow‐up data from the Hisayama study. Journal of Diabetes Investigation. 13(10). 1677–1684. 3 indexed citations

Hata, Jun, Tomomi Ide, Takuya Nagata, et al.. (2021). Urinary N-terminal pro–B-type natriuretic peptide as a biomarker for cardiovascular events in a general Japanese population: the Hisayama Study. Environmental Health and Preventive Medicine. 26(1). 47–47. 2 indexed citations

Yoshida, Daigo, Takanori Honda, Jun Hata, et al.. (2020). Prevalence and Mortality of Sarcopenia in a Community-dwelling Older Japanese Population: The Hisayama Study. Journal of Epidemiology. 31(5). 320–327. 41 indexed citations

Kimura, Yasumi, Daigo Yoshida, Yoichiro Hirakawa, et al.. (2020). Dietary fiber intake and risk of type 2 diabetes in a general Japanese population: The Hisayama Study. Journal of Diabetes Investigation. 12(4). 527–536. 30 indexed citations

Hachiya, Tsuyoshi, Jun Hata, Yoichiro Hirakawa, et al.. (2020). Genome-Wide Polygenic Score and the Risk of Ischemic Stroke in a Prospective Cohort. Stroke. 51(3). 759–765. 22 indexed citations

Hirakawa, Yoichiro, Jun Hata, Masahito Yoshinari, et al.. (2020). 30-minute postload plasma glucose levels during an oral glucose tolerance test predict the risk of future type 2 diabetes: the Hisayama Study. BMJ Open Diabetes Research & Care. 8(1). e001156–e001156. 5 indexed citations

Ogata, Hiroaki, Yoichiro Hirakawa, Koichiro Matsumoto, et al.. (2019). Trends in the prevalence of airflow limitation in a general Japanese population: two serial cross-sectional surveys from the Hisayama Study. BMJ Open. 9(3). e023673–e023673. 7 indexed citations

10.

Hata, Jun, Tomoyuki Ohara, Yoshinori Katakura, et al.. (2019). Association Between Serum β-Alanine and Risk of Dementia. American Journal of Epidemiology. 188(9). 1637–1645. 27 indexed citations

11.

Yoshida, Daigo, Tomoyuki Ohara, Jun Hata, et al.. (2019). Dairy consumption and risk of functional disability in an elderly Japanese population: the Hisayama Study. American Journal of Clinical Nutrition. 109(6). 1664–1671. 15 indexed citations

12.

Tanaka, Masashi, Takanori Honda, Hajime Yamakage, et al.. (2018). A potential novel pathological implication of serum soluble triggering receptor expressed on myeloid cell 2 in insulin resistance in a general Japanese population: The Hisayama study. Diabetes Research and Clinical Practice. 146. 225–232. 8 indexed citations

13.

Furuta, Yoshihiko, Jun Hata, Naoko Mukai, et al.. (2018). Secular trends in the incidence, risk factors, and prognosis of transient ischemic attack in Japan: The Hisayama Study. Atherosclerosis. 273. 84–90. 3 indexed citations

14.

Honda, Takanori, Daigo Yoshida, Jun Hata, et al.. (2018). Development and validation of modified risk prediction models for cardiovascular disease and its subtypes: The Hisayama Study. Atherosclerosis. 279. 38–44. 20 indexed citations

15.

Nakamura, Udai, Masanori Iwase, Hiroki Fujii, et al.. (2017). The gene–treatment interaction of paraoxonase-1 gene polymorphism and statin therapy on insulin secretion in Japanese patients with type 2 diabetes: Fukuoka diabetes registry. BMC Medical Genetics. 18(1). 146–146. 6 indexed citations

16.

Gotoh, Seiji, Jun Hata, Toshiharu Ninomiya, et al.. (2015). Hematocrit and the risk of cardiovascular disease in a Japanese community: The Hisayama Study. Atherosclerosis. 242(1). 199–204. 50 indexed citations

17.

Hirakawa, Yoichiro, Hisatomi Arima, Sophia Zoungas, et al.. (2014). Impact of Visit-to-Visit Glycemic Variability on the Risks of Macrovascular and Microvascular Events and All-Cause Mortality in Type 2 Diabetes: The ADVANCE Trial. Diabetes Care. 37(8). 2359–2365. 283 indexed citations

18.

Ohkuma, Toshiaki, Hiroki Fujii, Masanori Iwase, et al.. (2013). U-shaped association of sleep duration with metabolic syndrome and insulin resistance in patients with type 2 diabetes: The Fukuoka Diabetes Registry. Metabolism. 63(4). 484–491. 62 indexed citations

19.

Ohkuma, Toshiaki, Hiroki Fujii, Masanori Iwase, et al.. (2012). Impact of eating rate on obesity and cardiovascular risk factors according to glucose tolerance status: the Fukuoka Diabetes Registry and the Hisayama Study. Diabetologia. 56(1). 70–77. 62 indexed citations

20.

Ohara, Tomoyuki, Toshiharu Ninomiya, Michiaki Kubo, et al.. (2011). Apolipoprotein Genotype for Prediction of Alzheimer's Disease in Older Japanese: The Hisayama Study. Journal of the American Geriatrics Society. 59(6). 1074–1079. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact